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Abstract
Background: The objective of this study was to evaluate the risk of benign peripheral persistent vertigo (BPPV)
among patients with anxiety disorders by using the Taiwan National Health Insurance Research Database (NHIRD).
Methods: We conducted a retrospective study of 15,470 participants (7735 anxiety disorder patients and 7735
control patients) selected from the NHIRD. Patients were observed for a maximum of 9 years to determine the rates
of newly diagnosed BPPV. A Cox regression model was used to evaluate the risk of BPPV among the patients with
anxiety disorders.
Results: During the 9-year follow-up period, 178 (2.05 per 1000 person-years) anxiety disorder patients and 71 (0.81
per 1000 person-years) control patients were diagnosed with BPPV. The incidence risk ratio of BPPV between
anxiety disorder patients and control patients was 2.52 (95 % confidence interval [CI], 1.90–3.37, P < .001). After
adjustment for age, sex, and comorbidities, patients with anxiety disorders were found to be 2.17 times more likely
to develop BPPV (95 % CI, 1.63–2.90, P < .001) than the control patients. Furthermore, female sex (HR = 1.81, 95 % CI,
1.31–2.50, P < .001) and cerebrovascular disease (HR = 1.53, 95 % CI, 1.00–2.34, P = .050) were independent risk
factors for developing new-onset BPPV in patients with anxiety disorders.
Conclusions: Anxiety disorder patients may have an increased risk of developing BPPV, especially those who are
female or have cerebrovascular disease.
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Background
Anxiety disorders are the most prevalent mental disorders.
Various population surveys have shown substantial dis-
crepancies in prevalence rates. According to the European
Study of the Epidemiology of Mental Disorders [1, 2], as
many as 33.7 % of people are affected by an anxiety dis-
order during their lifetime, among whom generalized anx-
iety disorder accounts for 6.2 % and panic disorder 5.2 %.
There is a consistent finding that the prevalence of anxiety
disorders occurs roughly twice as often in females as in
males [1, 3]. Anxiety disorders cause significant quality-of-
life impairment [4] and are associated with immense
health care costs [1, 5].
Benign paroxysmal positional vertigo (BPPV) is the most
common type of peripheral vertigo [6] and is generally as-
sociated with nausea and vomiting. The symptoms are
caused by the otoliths’ detaching from the macula and en-
tering the semicircular canals [6]. BPPV attacks may be
related to head trauma, a prolonged recumbent position,
and various pathological processes such as inflammation
of the inner ears. According to previous studies, the pres-
ence of a systemic disease, including hypertension, dia-
betes, high cholesterol, cerebrovascular diseases, and
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autoimmune diseases such as allergies and thyroid auto-
immunity, may worsen the status of the posterior laby-
rinth, causing a more frequent otolith detachment and, in
turn, BPPV [7–10]. However, in most BPPV cases, the eti-
ology is idiopathic [11]. Patients typically present with fre-
quent spontaneous remissions and recurrences. The
recurrence rate per year is approximately 15 % [12]. Add-
itionally, patients with BPPV are at higher risks of falls
and impairment in the performance of daily activities [13].
Previous studies have reported that the prevalence of
BPPV is between 10.7 and 64.0 cases per 100,000 persons,
with a lifetime prevalence of 2.4 % [14]. In addition, epi-
demiological studies have demonstrated that the preva-
lence of idiopathic BPPV is higher among women and
older adults of both sexes, with the peak onset between 50
and 60 years of age and a female-to-male ratio between
2:1 and 3:1 [14, 15].
Although vertigo is a common somatic complaint among
patients with anxiety disorders, to our knowledge, only one
case-controlled study has investigated the association be-
tween anxiety and subsequent BPPV. The results of the
previous study indicated that anxiety disorders may be con-
sidered a precursor of BPPV [16]. However, the sample size
of the case-controlled study was small, with 100 partici-
pants enrolled. In addition, the study used a self-reported
rating scale for evaluating the severity of anxiety rather
than diagnosis by a psychiatrist, which may have limited
the clinical impact and its generalizability.
Several studies have reported an increased incidence of
vestibular dysfunction among patients with anxiety disor-
ders. In addition, evidence shows that vestibular dysfunc-
tion is considered one of the pathogeneses for BPPV.
Moreover, numerous studies have confirmed the neural in-
flammation and impaired neuroendocrine response in pa-
tients with anxiety, and both of the similar inflammatory
processes and neuroendocrine dysfunction are regarded as
crucial elements in the pathophysiology of BPPV. There-
fore, we hypothesized that anxiety disorders may play cru-
cial roles in the development of subsequent BPPV. In
response to the lack of national data in Asian areas and
few longitudinal studies concerning the association be-
tween anxiety disorders and the risk of BPPV, we designed
a nationwide population-based study to investigate the in-
cidence of new-onset BPPV among patients with anxiety
disorders. Furthermore, possible independent risk factors
including hypertension, diabetes mellitus, hyperlipidemia,
cerebrovascular disease, autoimmune diseases, and other
possible systemic diseases for BPPV among patients with
anxiety disorders were identified and analyzed.
Methods
Data sources
In 1995, Taiwan launched the NHI program, which covers
99 % of Taiwan’s population [17]. The NHI program offers
universal medical care, including outpatient, inpatient, and
emergency care, as well as traditional Chinese medicinal
treatment. The NHI research database (NHIRD) contains
comprehensive information regarding clinical visits, includ-
ing prescription details and diagnostic codes based on the
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM). The NHIRD is man-
aged by the National Health Research Institutes (NHRI),
and confidentiality is maintained according to the direc-
tives of the Bureau of the NHI [18]. The data source for
our study was the Longitudinal Health Insurance Database
2000 (LHID 2000), which is a data set of the NHIRD. Data
for the LHID were collected through both systematic and
random sampling from the NHIRD; the database com-
prised data on one million individuals. The NHRI claims
data indicated no significant differences in sex and age dis-
tribution or in average insured payroll-related amounts be-
tween the patients in the LHID and those in the original
NHIRD [18].
Study population
A retrospective cohort study was conducted using data
extracted from the LHID 2000. Patients aged 20 years
and older who were newly diagnosed with anxiety disor-
ders between January 1, 2000, and December 31, 2004,
were enrolled. The term “anxiety disorders” was defined in
accordance with ICD-9-CM codes 300.0, 300.2, and 308.3.
To ensure the accuracy of anxiety disorder diagnosis, only
patients who were diagnosed with anxiety disorders by a
psychiatrist were selected. In both the anxiety disorder and
control groups, we excluded patients who were diagnosed
with BPPV (ICD-9-CM code 386.11) prior to the enroll-
ment date. Finally, we identified 7735 patients with anxiety
disorders. To assemble a comparison cohort, we randomly
selected 7735 enrollees without a history of anxiety dis-
orders. These controls were matched with the study co-
hort at a ratio of 1:1 by age and sex according to the same
exclusion criteria during the same period. To increase
the diagnosis validity, only neurologist-diagnosed BPPV
or otorhinolaryngologist-diagnosed BPPV was included
as our primary clinical outcome. The participants in both
the study and control cohorts were observed until being
diagnosed with BPPV by a neurologist or an otorhino-
laryngologist, death, withdrawal from the NHI system, or
December 31, 2013.
Statistical analysis
The incidence of newly diagnosed BPPV in the anxiety
disorder and control patients was calculated and strati-
fied by sex and age (older or younger than 60 years). In-
dependent t tests and chi-square tests were used to
examine the differences in the demographic characteris-
tics between the anxiety disorder and control patients.
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For each patient diagnosed with BPPV who was in-
cluded in the study, the relevant period for calculating
person-years at risk began on the enrollment date and
ended on the date of BPPV diagnosis by a neurologist or
an otorhinolaryngologist, death, withdrawal from the
NHI system, or December 31, 2013. The same calcula-
tion was used for each person in the control cohort.
In our study, in addition to investigating whether pa-
tients with anxiety disorders have a higher risk of devel-
oping subsequent BPPV than that of control patients, we
sought to identify the variables that are potential pre-
dictive factors for developing BPPV among patients with
anxiety disorders. Therefore, a Cox proportional hazards
regression model was employed twice: once for identify-
ing possible confounding variables and excluding their
effects on the process of evaluating whether anxiety dis-
orders increase the risk of subsequent BPPV (Table 3),
and once for attempting to identify the variables that
may indicate subsequent BPPV among patients with
anxiety disorders (Table 4). The variables used in the
Cox model were age, sex, and common comorbidities,
including hypertension, diabetes mellitus, chronic liver
disease, autoimmune disease, congestive heart failure,
hyperlipidemia, nephropathy, cerebrovascular disease,
and chronic obstructive pulmonary disease (COPD). The
variables that demonstrated a moderately significant
statistical relationship with BPPV in the univariate ana-




The sample comprised 7735 anxiety disorder patients
and 7735 control patients without anxiety disorders.
Among both cohorts, 58.3 % were female. The median
age of both cohorts on the enrollment date was 43 years
(interquartile range [IQR], 33–55 years), and the median
follow-up period was 11.24 years (IQR, 9.97–12.61 years)
for the anxiety disorder patients and 11.27 years (IQR,
10.00–12.64 years) for the control patients. Comorbidi-
ties, including hypertension, diabetes mellitus, chronic
liver disease, autoimmune disease, congestive heart fail-
ure, hyperlipidemia, nephropathy, cerebrovascular dis-
ease, and COPD, were more common in the anxiety
disorder cohort than in the control cohort. A compari-
son of the demographic and clinical variables between
the anxiety disorder and control patients is presented in
Table 1.
Incidence rate of BPPV
During the study period, 178 (2.05 per 1000 person-
years) patients with anxiety disorders and 71 (0.81 per
1000 person-years) control patients were diagnosed with
BPPV. The incidence risk ratio (IRR) of BPPV between
the anxiety disorder patients and control patients was
2.52 (95 % confidence interval [CI], 1.90–3.37, P < .001).
When stratified by sex and age, the IRR of BPPV was
still higher in the patients with anxiety disorders than in
the control patients. The results are shown in Table 2.
The cumulative incidence of BPPV in the patients with
anxiety disorders was significantly higher than that in
the control cohort (log-rank test, P < .001, Fig. 1).
Effects of anxiety disorders on risk of BPPV
After adjustment for age, sex, and comorbidities, the
hazard ratio (HR) for developing BPPV after anxiety dis-
order diagnosis during the follow-up period was 2.17
times (95 % CI, 1.63–2.90, P < .001) greater than that of
the control cohort (Table 3).
Risk factors for BPPV in patients with anxiety disorders
We applied a univariate analysis to identify the possible risk
factors for subsequent BPPV in the anxiety disorder cohort.
The results are displayed in Table 4, demonstrating that
older age (HR = 1.50, 95 % CI, 1.07–2.10, P = .019), female
sex (HR = 1.74, 95 % CI, 1.26–2.41, P = .001), hypertension
(HR = 1.56, 95 % CI, 1.14–2.12, P = .005), diabetes mellitus
(HR = 1.99, 95 % CI, 1.17–3.37, P = .011), hyperlipidemia
(HR = 3.74, 95 % CI, 1.67–8.38, P < .001), cerebrovascular
disease (HR = 1.90, 95 % CI, 1.29–2.80, P = .001), and
COPD (HR = 1.47, 95 % CI, 1.06–2.04, P = .021) are pos-
sible risk factors for subsequent BPPV. After the multivari-
ate analysis, we confirmed that female sex (HR = 1.81, 95 %
CI, 1.31–2.50, P < .001) and cerebrovascular disease (HR =
1.53, 95 % CI, 1.00–2.34, P = .050) were independent risk
factors for subsequent BPPV development in the patients
with anxiety disorders.
Discussion
According to our thorough research, this is the first
large nationwide population-based cohort study to com-
pare the HRs for newly diagnosed BPPV in patients with
and without anxiety disorders. The two major findings
of this study are as follows. First, the risk of BPPV was
significantly higher among the patients with anxiety dis-
orders. Second, we suggest that female sex and cerebro-
vascular disease may be considered risk factors for
developing subsequent BPPV among patients with anx-
iety disorders.
Psychiatric comorbidities in vestibular disorders, such
as Meniere’s disease and vestibular neuronitis, have been
broadly described [19–26]. Nevertheless, few studies
have examined psychiatric disorders as precursors of
BPPV. Monzani et al. investigated this concern by using
a case-controlled study of 100 participants; the results
showed that higher levels of anxiety may be considered a
precursor of BPPV [16]. This finding was consistent with
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our results and reinforces the dependability of our study
findings.
No direct pathophysiological link between anxiety dis-
orders and BPPV has been established. We postulated
several possible mechanisms for the increased risk of
BPPV in patients with anxiety disorders. First, a higher
prevalence of vestibular dysfunction in anxiety patients
may result in BPPV development. The literature demon-
strates that abnormal vestibular sensitivity occurs in anx-
iety patients [27], and vestibular dysfunction is regarded
as one of the pathogeneses for BPPV [28, 29]. Second,
an anxiety-disorder-related inflammatory response may
result in subsequent BPPV development. Numerous
studies have proposed a relationship between anxiety
disorders and inflammatory processes [30–33], and
neural inflammation is known to play a crucial role in
the pathophysiology of BPPV [34, 35]. Third, an im-
paired neuroendocrine response induced by anxiety dis-
orders may cause BPPV. Anxiety disorders are presumed
to result in abnormal activation of the hypothalamus–pi-
tuitary–adrenal axis, which may induce dysfunction of
neuroendocrine responses [36]. This neuroendocrine
dysfunction results in inner ear blood flow imbalance
[37], thus influencing otoconial homeostasis [16, 38],
which has been considered a potential risk factor for de-
veloping BPPV [37].
Another finding of this study was that female sex and
cerebrovascular disease may be risk factors for develop-
ing BPPV among patients with anxiety disorders. As
mentioned previously, BPPV occurs more often in
Table 2 Incidence of benign paroxysmal positional vertigo in patients with and without anxiety disorders
Patients with anxiety disorders Patients without anxiety disorders Risk ratio (95 %
CI)
P
valueNo. of BPPV Per 1000 person-years No. of BPPV Per 1000 person-years
Total 178 2.05 71 0.81 2.52 (1.90–3.37) <.001
Age
≥ 60 45 2.82 16 0.99 2.85 (1.58–5.39) <.001
< 60 133 1.87 55 0.77 2.43 (1.76–3.39) <.001
Sex
Male 52 1.43 25 0.68 2.09 (1.27–3.51) .002
Female 126 2.49 46 0.90 2.76 (1.95–3.96) <.001
CI indicates confidence interval
Table 1 Baseline characteristics of patients with and without anxiety disorders
Demographic data Patients with anxiety disorders Patients without anxiety disorders P value
n = 7735 n = 7735
n % n %
Age (years)a 43 (33–55) 43 (33–55)
≥ 60 1417 18.3 1417 18.3 >.999
< 60 6318 81.7 6318 81.7
Sex
Male 3225 41.7 3225 41.7 >.999
Female 4510 58.3 4510 58.3
Comorbidities
Hypertension 1932 25.0 966 12.5 <.001
Diabetes mellitus 358 4.6 230 3.0 <.001
Chronic liver diseases 2314 29.9 857 11.1 <.001
Autoimmune diseases 679 8.8 311 4.0 <.001
Congestive heart failure 234 3.0 101 1.3 <.001
Hyperlipidemia 1411 18.0 620 8.0 <.001
Nephropathy 696 9.0 274 3.5 <.001
Cerebrovascular disease 792 10.2 279 3.6 <.001
COPD 1682 21.7 779 10.1 <.001
Follow-up yearsa 11.24 (9.97–12.61) 11.27 (10.00–12.64) .012
aMedian (interquartile range); COPD indicates chronic obstructive pulmonary disease
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females than in males [14], with a female-to-male ratio
of between 2:1 and 3:1, which may explain the results of
our study. In addition, previous studies have advocated
disruption of the anterior vestibular artery as an etiology
of BPPV [39], which may explain why cerebrovascular
disease is a risk factor for developing BPPV. Disruption
of the anterior vestibular artery results in degeneration
of the otolith, increasing the probability of the otolith’s
floating into the semicircular canals, thereby promoting
the development of BPPV [39]. Furthermore, evidence
shows that microcirculatory damage is associated with
sensory epithelial dysfunction in the inner ear, which ex-
acerbates detachment of the otolith from the otolith
membrane and impairs absorption of the otolith in ves-
tibular dark cells, thereby inducing the onset of BPPV
[10, 40].
The strengths of our study are the large sample size
and the valid diagnosis of anxiety disorders and BPPV
Fig. 1 Cumulative incidence of benign paroxysmal positional vertigo in anxiety disorders and comparison cohort. The cumulative incidence of
benign paroxysmal positional vertigo in patients with anxiety disorders was significantly higher than that in the comparison cohort
Table 3 Analyses of risk for benign paroxysmal positional vertigo in patients with and without anxiety disorders
Predictive variables Univariate analysis Multivariate analysis
HR (95 % CI) P value HR (95 % CI) P value
Anxiety disorders 2.52 (1.92–3.32) <.001 2.17 (1.63–2.90) <.001
Age (≥60 = 1, <60 = 0) 1.44 (1.08–1.92) .014 1.09 (0.78–1.53) .601
Sex (female = 1, male = 0) 1.60 (1.23–2.10) .001 1.65 (1.26–2.17) <.001
Comorbidities
Hypertension 1.76 (1.34–2.32) <.001 1.06 (0.75–1.48) .751
Diabetes mellitus 1.93 (1.18–3.15) .009 1.18 (0.70–1.99) .528
Chronic liver diseases 1.48 (1.12–1.96) .006 0.95 (0.70–1.29) .719
Autoimmune diseases 1.28 (0.80–2.04) .309
Congestive heart failure 1.95 (1.04–3.67) .039 1.02 (0.52–1.98) .958
Hyperlipidemia 2.06 (1.53–2.76) <.001 1.36 (0.96–1.92) .084
Nephropathy 2.46 (1.72–3.54) <.001 1.69 (1.14–2.48) .008
Cerebrovascular disease 2.33 (1.64–3.32) <.001 1.51 (1.02–2.24) .039
COPD 1.87 (1.40–2.49) <.001 1.35 (0.99–1.84) .055
HR indicates hazard ratio, CI indicates confidence interval, COPD indicates chronic obstructive pulmonary disease
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by experts in the claims database. Nevertheless, certain
limitations of our findings should be considered. First,
the NHIRD does not provide detailed information on
several factors that may have been crucial confounding
variables in our study, such as tobacco use, alcohol con-
sumption, favored sleeping position, and family history
of BPPV. In 2006, Sunami et al. reported that smoking
and alcohol consumption were associated with a lower
incidence of BPPV [41]. One study reported that an ear-
down 45° head position during sleep may be an etio-
logical factor for BPPV; possibly because this position
makes it easier for detached otoconia to fall into the
posterior or lateral semicircular canal [42]. In addition, a
previous study revealed a familial tendency for the oc-
currence of BPPV [43]. Second, deviations in the coding
of the claims data were inevitable. In our study, we
attempted to achieve high validity by obtaining coding
from a psychiatrist, neurologist, or otorhinolaryngologist.
In addition, a matched control cohort was used to offset
possible coding errors and minimize bias. However, thus
far, there has been no validation study of the diagnosis
and/or severity of anxiety disorders that involved using
the NHIRD as a research database. Third, the prevalence
of anxiety disorders and BPPV may be underestimated
because only subjects seeking medical evaluation could
be identified; however, this most likely resulted in under-
estimating the association between anxiety disorders and
BPPV. Finally, information regarding the severity of anx-
iety disorders is lacking in the NHIRD; thus, we could
not investigate the impact of the severity of anxiety dis-
orders on BPPV in this study.
Conclusions
Our nationwide population-based retrospective cohort
study provides further evidence for an increased risk of
BPPV in patients with anxiety disorders. Clinicians should
be aware of the possibility of new-onset BPPV in anxiety
disorder patients. Prospective studies, especially those
with greater access to patient-level data, are warranted to
confirm our findings.
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